Rick, I am pretty busy right now trying to figure out if I can sue Paul for giving out inside information on prln. Don't tell anyone because I don't want to do it until after the dinner unless I can use the threat to leverage Paul up to taking us on that trip he mentioned awhile back. But re prln stock movement, I think if new buyers don't create upward pressure the powers that be will be able to pick their point of entry and, if we are right about the ultimate value of prln, that point will not correlate with anything reasonable like marketing news or product sales news, it will come at some point that makes no sense, maybe even during a general market down draft.
I do take issue with your advocating leaving the dogs and others behind (although I doubt they are currently occupying a front burner) 1) the meek are scheduled to inherit the earth 2) we should check with Paul about the possibility that some of these veterinary efforts can bring even a dog like ccee back to life :-) Seriously, I thank many of the prln developments came from veterinarian research and, as I recall, John Babbish comes from the veterinarian field, himself. And this may not be totally separate, as I see it, from his reputation for being committed to the ultimate benefit to patients of prln products rather than to the price of the medication or the stock, and that is fine with me even though it may not please market manipulators who would love to have inside sympathy with their efforts in whichever direction they are moving.
Larry |
